These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6733721)

  • 1. Preclinical evaluation of the anti tumour activity of new epoxyde derivatives.
    Atassi G; Dumont P; Fisher U; Zeidler M; Budnowski M
    Cancer Treat Rev; 1984 Mar; 11 Suppl A():99-110. PubMed ID: 6733721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the activity of alpha/beta-triglycidylurazol (TGU; NSC-332488): a new antineoplastic compound.
    Atassi G; Dumont P; Vanhaelen C
    Eur J Cancer Clin Oncol; 1984 Sep; 20(9):1187-91. PubMed ID: 6541138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-/beta-Triglycidyl-urazol (TGU, NSC 332488, I.N.N.: ANAXIRONE): a new chemotherapeutic agent.
    Hilgard P; Peukert M; Pohl J
    Cancer Treat Rev; 1984 Jun; 11(2):115-20. PubMed ID: 6498858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the antitumor activity of new epoxide derivatives. Part II: N-glycidylated oxo-nitrogen heterocycles.
    Fischer H; Möller H; Budnowski M; Atassi G; Dumont P; Venditti J; Yoder OC
    Arzneimittelforschung; 1984; 34(6):663-8. PubMed ID: 6541486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase-I study of alpha-1,3,5-triglycidyl-s-triazinetrione (NSC 296934).
    Dombernowsky P; Lund B; Hansen HH
    Cancer Chemother Pharmacol; 1983; 11(1):59-61. PubMed ID: 6883626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a delta 5-homo-aza-steroidal ester in P388 and L1210 murine leukemias.
    Catsoulacos P; Camoutsis C; Wampler GL
    Oncology; 1982; 39(1):59-60. PubMed ID: 7058047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of novel ailanthone derivatives in vitro and in vivo.
    Kato T; Suzumura Y; Fukushima M; Honda T; Nakanishi T; Noguchi T
    Anticancer Res; 1988; 8(4):573-9. PubMed ID: 3178149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic studies of a novel antitumor drug, alpha-1,3,5-triglycidyl-s-triazinetrione. Antitumor and cytotoxic effects.
    WU FY; Le Pecq JB
    Mol Pharmacol; 1983 Jan; 23(1):182-9. PubMed ID: 6346048
    [No Abstract]   [Full Text] [Related]  

  • 9. An in vitro assay for evaluating chemosensitivity of leukaemia cells: preclinical studies.
    Menconi E; Lepri E; Bonmassar E; Frati L; Barzi A
    Int J Tissue React; 1986; 8(6):485-92. PubMed ID: 3793386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WF-3405, a novel antitumor antibiotic. Taxonomy, isolation, structure elucidation and biological properties.
    Kiyoto S; Murai H; Tsurumi Y; Terano H; Kohsaka M; Takase S; Uchida I; Hashimoto M; Aoki H; Imanaka H
    J Antibiot (Tokyo); 1987 Mar; 40(3):290-5. PubMed ID: 3570981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new antitumour agent, batracylin, selected by a preclinical solid tumour model.
    Atassi G; Dumont P; Kabbe HJ; Yoder O
    Drugs Exp Clin Res; 1988; 14(9):571-4. PubMed ID: 3229319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New anti-bilharzial derivatives of epoxy-1,2-propylphosphonic acid. I].
    Chabrier P; Nguyen Thanh Thuong ; Warolin C; Dodin A
    Bull Soc Pathol Exot Filiales; 1977; 70(2):166-8. PubMed ID: 579616
    [No Abstract]   [Full Text] [Related]  

  • 13. [New anti-bilharzial derivatives of epoxy-1,2-propylphosphonic acid. II].
    Chabrier P; Nguyen Thanh Thuong ; Warolin C; Dodin A
    Bull Soc Pathol Exot Filiales; 1977; 70(2):168-71. PubMed ID: 579617
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.
    Rose WC; Schurig JE; Huftalen JB; Bradner WT
    Cancer Res; 1983 Apr; 43(4):1504-10. PubMed ID: 6831399
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis, antitumor activity, and DNA binding properties of a new derivative of amsacrine, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino) phenylamino]-4-acridinecarboxamide.
    Baguley BC; Denny WA; Atwell GJ; Finlay GJ; Rewcastle GW; Twigden SJ; Wilson WR
    Cancer Res; 1984 Aug; 44(8):3245-51. PubMed ID: 6547635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo antitumor activity of 6-benzyl-1,3-benzodioxole derivatives against the P388, L1210, B16, and M5076 murine models.
    Jurd L; Narayanan VL; Paull KD
    J Med Chem; 1987 Oct; 30(10):1752-6. PubMed ID: 2821258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the antitumor activity of new epoxide derivatives. Part I: s-Triazinetrione derivatives.
    Fischer H; Zeidler U; Budnowski M; Atassi G; Dumont P; Venditti J; Yoder OC
    Arzneimittelforschung; 1984; 34(5):543-7. PubMed ID: 6540567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and cytotoxic activity of pyridylthio, pyridylsulfinyl, and pyridylsulfonyl methyl acrylates.
    Phillips OA; Nelson LA; Knaus EE; Allen TM; Fathi-Afshar R
    Drug Des Deliv; 1989 Mar; 4(2):121-7. PubMed ID: 2765104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of the novel nitrosourea S10036 in rodent tumors.
    Filippeschi S; Colombo T; Bassani D; De Francesco L; Arioli P; D'Incalci M; Bartosek I; Guaitani A
    Anticancer Res; 1988; 8(6):1351-4. PubMed ID: 3064716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A characterization of the activity of alpha-1,3,5-triglycidyl-s-triazinetrione, a novel antineoplastic compound.
    Spreafico F; Atassi G; Filippeschi S; Malfiore C; Noseda S; Boschetti D
    Cancer Chemother Pharmacol; 1980; 5(2):103-8. PubMed ID: 7471313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.